Godavari Biorefineries is currently trading at Rs. 274.40, down by 1.85 points or 0.68% from its previous closing of Rs. 272.55 on the BSE.
The scrip opened at Rs. 278.00 and has touched a high and low of Rs. 278.00 and Rs. 270.95 respectively. So far 1337 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 355.70 on 18-Dec-2024 and a 52 week low of Rs. 145.20 on 28-Mar-2025.
Last one week high and low of the scrip stood at Rs. 280.80 and Rs. 248.45 respectively. The current market cap of the company is Rs. 1389.43 crore.
The promoters holding in the company stood at 63.31%, while Institutions and Non-Institutions held 12.58% and 24.12% respectively.
Godavari Biorefineries has incorporated Sathgen Therapeutics LLC, a wholly owned step down subsidiary based in Princeton, New Jersey, USA. This strategic expansion strengthens the company’s clinical stage biotechnology presence in the United States, with a primary focus on global out-licensing of intellectual property and to build the network to accelerate the drug-development programme.
Sathgen Therapeutics has also formed a Scientific Advisory Board (SAB) to guide its clinical-development and translational-research strategy. The SAB includes Razelle Kurzrock, an internationally known authority in precision oncology, immunotherapy, and early-phase clinical trials, and Massimo Cristofanilli, a leading global expert in metastatic breast cancer and cancer biology.
Godavari Biorefineries is one of the manufacturers of ethanol-based chemicals in India. Its diversified product portfolio comprises of bio-based chemicals, sugar, different grades of ethanol and power.
| Company Name | CMP |
|---|---|
| Shree Renuka Sugar | 27.28 |
| Bajaj Hindusthan Sug | 17.76 |
| Triveni Engg. & Inds | 383.15 |
| Balrampur Chini Mill | 473.45 |
| Dalmia Bharat Sugar | 371.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: